Levocetirizine in the treatment of chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled study

British Journal of Dermatology

Volumn 154, Issue 3, 2006, Pages 533-538

  Nettis, E ^a   Colanardi, M C ^a   Barra, L ^a   Ferrannini, A ^a   Vacca, A ^a   Tursi, A ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Chronic idiopathic urticaria; Levocetirizine; Placebo controlled study; Randomized controlled trial

Indexed keywords

LEVOCETIRIZINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYMPTOM; URTICARIA;

ADULT; AGED; CETIRIZINE; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PRURITUS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URTICARIA;

EID: 33644914178     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.07049.x     Document Type: Article

References (26)

1. Tillement JP A low distribution volume as a determinant of efficacy and safety for histamine (H1) antagonist Allergy 1995 50 12 16
2. Devalia JL de Vos C Hanotte F Baltes E A randomized double-blind crossover comparison among cetirizine, levocetirizine and UCB 28557 on histamine-induced cutaneous responses in healthy adult volunteers Allergy 2001 56 50 7
3. Grant JA Riethuisen JM Moulaert B de Vos C A double-blind, randomized, single dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects Ann Allergy Asthma Immunol 2002 88 190 7
4. Purohit A Melac M Pauli G Frossard N Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin Br J Clin Pharmacol 2003 56 388 94
5. Gandon JM Allain H Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers J Clin Pharmacol 2002 54 51 8
6. Wedi B Novacovic V Koemer M Kapp A Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression - inhibitory effects of anti-inflammatory drugs J Allergy Clin Immunol 2000 105 552 60
7. Salmun LM Antihistamines in late-phase clinical development for allergic disease Expert Opin Invest Drugs 2002 11 259 73
8. Clough GF Boutsiouki P Church MK Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin Allergy 2001 56 985 8
9. Finlay AY Khan GK Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use Clin Exp Dermatol 1994 19 210 16
10. Grattan C Powell S Humphreys F Management and diagnostic guidelines for urticaria and angio-oedema Br J Dermatol 2001 144 708 14
11. Greaves MW Chronic urticaria N Engl J Med 1995 332 1767 72
12. Nettis E Dambra P D'Oronzio L et al. Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria Clin Exp Dermatol 2002 27 29 31
13. Sabroe RA Seed PT Stat C et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies J Am Acad Dermatol 1999 40 443 50
14. Horan RF Ascneider LC Sheffer AL Allergic skin disorders and mastocytosis JAMA 1992 268 1858 68
15. Sabroe RA Greaves MW The pathogenesis of chronic idiopathic urticaria Arch Dermatol 1997 133 1003 8
16. Greaves MW Sabroe RA ABC of allergies: allergy and the skin. I - urticaria Br Med J 1998 316 1147 50
17. O'Donnell BF Lawlor F Simpson J et al. The impact of chronic urticaria on the quality of life Br J Dermatol 1997 136 197 201
18. Greaves M Chronic urticaria J Allergy Clin Immunol 2000 105 664 72
19. Schwartz LB Mast cells and their role in urticaria J Am Acad Dermatol 1991 25 190 204
20. Henderson WR The role of leukotrienes in inflammation Ann Intern Med 1994 121 684 97
21. Lewis RA Austen KF Soberman RJ Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases N Engl J Med 1990 323 645 55
22. Nettis E Colanardi MC Paradiso MT et al. Desloratadine in combination with montelukast in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study Clin Exp Allergy 2004 34 1401 7
23. Nettis E Pannofino A Cavallo E et al. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria J Allergy Clin Immunol 2003 112 212 13
24. Norris GJ Sullivan TJ Leukotrienes and cytokines in steroid dependent urticaria J Allergy Clin Immunol 1998 101 128 (Abstract).
25. Bagenstose SE Levin L Bernstain JA The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test J Allergy Clin Immunol 2004 113 134 40
26. Breneman D Bronsky EA Bruce S et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled comparative trial J Am Acad Dermatol 1995 33 192 8